Scilex (SCLX) News Today

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

$0.90

0.00 (0.00%)

(As of 04:38 PM ET)

Source

Source	Headline
	Scilex to reduce R&D expenses in 2024, comments on actions post Change Healthcare cyberattack msn.com - April 16 at 1:08 PM
	Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses globenewswire.com - April 16 at 9:00 AM
	Scilex (SCLX) & Its Peers Financial Comparison americanbankingnews.com - April 14 at 1:32 AM
	Financial Comparison: Scilex (SCLX) & Its Rivals americanbankingnews.com - April 13 at 1:44 AM
	Scilex (SCLX) & Its Rivals Head to Head Review americanbankingnews.com - April 10 at 1:24 AM
	Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool globenewswire.com - April 9 at 9:00 AM
	Reviewing Scilex (NASDAQ:SCLX) & TRACON Pharmaceuticals (NASDAQ:TCON) americanbankingnews.com - April 9 at 2:18 AM
	Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend globenewswire.com - March 27 at 9:00 AM
	Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients globenewswire.com - March 21 at 9:30 AM
	Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed globenewswire.com - March 20 at 11:00 AM
	Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex's Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba® globenewswire.com - March 20 at 9:00 AM
	Scilex Holding repays the remaining balance of convertible debentures msn.com - March 19 at 1:05 PM
	Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation globenewswire.com - March 19 at 9:00 AM
	Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada globenewswire.com - March 18 at 9:00 AM
	SCLX Apr 2024 2.000 put finance.yahoo.com - March 16 at 10:45 PM
	SCLX Apr 2024 1.000 put finance.yahoo.com - March 16 at 5:44 PM
	Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc. globenewswire.com - March 15 at 2:45 PM
	Scilex Pharma Enters Definitive Mutual Release And Settlement Agreement With Virpax markets.businessinsider.com - March 15 at 10:23 AM
	Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement finance.yahoo.com - March 15 at 10:23 AM
	Scilex Holding Company's Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement globenewswire.com - March 15 at 9:00 AM
	Zacks Small Cap Analysts Increase Earnings Estimates for Scilex Holding (NASDAQ:SCLX) marketbeat.com - March 15 at 6:49 AM
	Scilex Holding Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags finance.yahoo.com - March 14 at 12:53 PM
	SCLX Grows Revenue and Boosts Marketing finance.yahoo.com - March 12 at 7:58 PM
	Scilex Holding Company (NASDAQ:SCLX) most popular amongst private companies who own 57% of the shares, institutions hold 25% finance.yahoo.com - March 9 at 8:08 AM
	Q2 2024 EPS Estimates for Scilex Holding Boosted by Analyst (NASDAQ:SCLX) marketbeat.com - March 7 at 6:55 AM
	SCLX Continues to Make Strides msn.com - March 6 at 7:35 PM
	Scilex Holding Company Announces Closing of $10 Million Bought Deal Offering globenewswire.com - March 5 at 4:01 PM
	Scilex Holding Company Sets Launch Price of $595 per 150ml bottle of Gloperba®, its First and Only Liquid Oral Version of the Anti-Gout Medicine Colchicine Indicated for the Prophylaxis of Painful Gout Flares in Adults; Expected Plans to Launch in the First Half of 2024 globenewswire.com - March 5 at 9:00 AM
	Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information Updates globenewswire.com - March 4 at 9:00 AM
	Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024 globenewswire.com - March 2 at 3:25 PM
	Scilex Holding Shares Drop 31% After $10M Offering Prices marketwatch.com - March 1 at 3:22 PM
	Scilex to raise $10M via bough deal offering msn.com - February 29 at 10:31 PM
	Scilex Holding Company Announces $10 Million Bought Deal Offering globenewswire.com - February 29 at 5:32 PM
	Scilex Holding Company Announces Major Initiative with a Leading National Pharmacy Chain to Stock GLOPERBA® in Most of Their Stores Throughout the U.S. globenewswire.com - February 28 at 9:00 AM
	Scilex and Sorrento settle with Virpax and its founder Anthony Mack msn.com - February 27 at 9:21 AM
	Scilex Holding Company Announces Acceptance of Abstract for Poster and Oral Presentation at the Annual Meeting of the American Academy of Pain Medicine (AAPM) globenewswire.com - February 27 at 9:00 AM
	Latest News for Scilex Holding Stock (NASDAQ:SCLX) benzinga.com - February 26 at 11:16 PM
	Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement finance.yahoo.com - February 26 at 6:15 PM
	Scilex Holding Company's Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement globenewswire.com - February 26 at 4:53 PM
	Scilex Holding Company Announces that ZTlido® Achieves a Major Milestone - Over One Million Patients Treated Since its Launch - and Two Additional Milestones Met globenewswire.com - February 26 at 9:00 AM
	Scilex Holding Company Announces Publication in Anesthesiology Journal of Results from an Investigator-Initiated Research Study Using ZTlido® for the Treatment of Chronic Neck Pain¹ globenewswire.com - February 20 at 9:00 AM
	Scilex Holding (NASDAQ:SCLX) Short Interest Update marketbeat.com - February 16 at 6:25 AM
	SCLX Sees Accelerating Revenue Growth finance.yahoo.com - January 30 at 12:33 PM
	Buy Rating Affirmed for Scilex Holding Amid Strong Product Performance and Improved Financial Outlook markets.businessinsider.com - January 26 at 11:56 PM
	HC Wainwright Weighs in on Scilex Holding's FY2023 Earnings (NASDAQ:SCLX) marketbeat.com - January 25 at 6:52 AM
	SCLX Jan 2024 2.000 put finance.yahoo.com - January 23 at 9:02 PM
	Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024 finance.yahoo.com - January 8 at 9:12 AM
	Scilex Holding Company estimates total product gross sales for fiscal year ended Dec 31 were between $150M and $155M msn.com - January 2 at 12:48 PM
	Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The Fiscal Year Ended December 31, 2023, Based On Currently Available Information finance.yahoo.com - January 2 at 12:48 PM
	SCLXW Scilex Holding Company WT EXP 111027 seekingalpha.com - December 21 at 2:44 PM

Get Scilex News Delivered to You Automatically

Will this $2 AI stock double overnight? (Ad)

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

Click here to learn more >>>

SCLX Media Mentions By Week

SCLX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SCLX
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

SCLX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SCLX Articles
This Week
▼
4

2
▲
SCLX Articles
Average Week

Get Scilex News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:SCLX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Scilex (SCLX) News Today

SCLX Media Mentions By Week

SCLX Media Sentiment

SCLX News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info